Retrospective 25 hospitalized patients treated with cephalosporin, azithromycin, and HCQ, and 217 SOC patients in South Korea, reporting no significant differences. 5 patients receiving lopinavir/ritonavir and HCQ >5 days were excluded for unknown reasons. HCQ was typically initiated based on progression or side effects from another treatment. Conflicting results are reported. Table 2 indicates 15 CA/HCQ patients after matching, while Table S2 shows 25, and the Table 3 count is blank. S2 appears to incorrectly show before matching results, and the after matching results are missing in Table 3. 200mg HCQ bid.
recovery time, 24.9% lower, HR 0.75, p = 0.45, treatment 15, control 15, propensity score matching.
|
hospitalization time, 12.7% higher, HR 1.13, p = 0.75, treatment 15, control 15, propensity score matching.
|
viral clearance time, 0.5% lower, HR 1.00, p = 0.99, treatment 15, control 15, propensity score matching.
|
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
|
Hong et al., 5/4/2022, retrospective, South Korea, Asia, peer-reviewed, 11 authors, study period 28 February, 2020 - 28 April, 2020.
Contact:
kmedicsoon@pusan.ac.kr, thhwang@pusan.ac.kr, wsabf@naver.com.